This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Inder, W. J. Articles by Hunt, P. J. Search for Related Content PubMed PubMed Citation Articles by Inder, W. J. Articles by Hunt, P. J.

Glucocorticoid Replacement in Pituitary Surgery: Guidelines for Perioperative Assessment and Management

Department of Medicine (W.J.I.), St. Vincent’s Hospital and University of Melbourne, Melbourne, Australia 3065; and Department of Endocrinology (P.J.H.), Christchurch Hospital, Christchurch, New Zealand 8001

Address all correspondence and requests for reprints to: Warrick Inder, M.D., Department of Medicine St. Vincent’s Hospital, 41 Victoria Parade, Fitzroy VIC 3065, Australia. E-mail: . winder{at}medstv.unimelb.edu.au

Abstract

Patients undergoing surgical resection of pituitary adenomas are frequently given perioperative glucocorticoid therapy. There are no randomized controlled studies assessing the need for such steroids; however, several studies have documented changes in the hypothalamic-pituitary-adrenal (HPA) axis associated with pituitary surgery. Based on the evidence available, this article details recommendations for the perioperative management of glucocorticoid therapy in patients with pituitary tumors. For patients with proven ACTH deficiency preoperatively [usually based on response to a short ACTH 1–24 (Synacthen) test], 48 h of supraphysiological glucocorticoid therapy should be administered perioperatively (e.g. hydrocortisone, 50 mg every 8 h on d 0, 25 mg every 8 h on d 1, and 25 mg at 0800 h on d 2). For patients with intact HPA function preoperatively, and in whom selective adenomectomy is possible, perioperative glucocorticoids are not necessary. Early postoperative assessment depends on daily clinical assessment of the patient and 0800 h plasma cortisol levels. Cortisol levels over 450 nM (16 µg/dl) reflect normal HPA function, and levels less than 100 nM (3.6 µg/dl) are consistent with ACTH deficiency. Cortisol levels between 100 and 250 nM (3.6–9 µg/dl) may be ACTH deficient and should receive morning hydrocortisone replacement until definitive HPA axis testing. Cortisol levels between 250 and 450 nM (9–16 µg/dl) are unlikely to be ACTH deficient but should receive additional steroids for stress until a definitive test is performed. For those requiring definitive testing, the insulin tolerance test, the overnight metyrapone test, or the glucagon stimulation test are appropriate and may be performed as early as d 7–10 or, if more convenient, wk 4–6. Following the guidelines suggested here should reduce the use of unnecessary glucocorticoids, while ensuring the safety of patients is not compromised.

This article has been cited by other articles:

				A. S. Dumont, E. C. Nemergut II, J. A. Jane Jr, and E. R. Laws Jr Postoperative Care Following Pituitary Surgery J Intensive Care Med, May 1, 2005; 20(3): 127 - 140. [Abstract] [PDF]

				A. Agha, B. Rogers, M. Sherlock, P. O'Kelly, W. Tormey, J. Phillips, and C. J. Thompson Anterior Pituitary Dysfunction in Survivors of Traumatic Brain Injury J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4929 - 4936. [Abstract] [Full Text] [PDF]

				C. H. Courtney, A. S. McAllister, P. M. Bell, D. R. McCance, H. Leslie, B. Sheridan, and A. B. Atkinson Low- and Standard-Dose Corticotropin and Insulin Hypoglycemia Testing in the Assessment of Hypothalamic-Pituitary-Adrenal Function after Pituitary Surgery J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1712 - 1717. [Abstract] [Full Text] [PDF]

				G. A. F. S. Rollin, N. P. Ferreira, M. Junges, J. L. Gross, and M. A. Czepielewski Dynamics of Serum Cortisol Levels after Transsphenoidal Surgery in a Cohort of Patients with Cushing's Disease J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1131 - 1139. [Abstract] [Full Text] [PDF]